In Reply We thank our colleagues at the American Society for Therapeutic Radiology and Oncology (ASTRO) for their letter supporting our Viewpoint on the sudden and concerning rise in use of electronic brachytherapy (EBT).1 Both the American Academy of Dermatology (AAD) position statement2 and ASTRO’s letter clearly show that major national specialty societies are putting quality care and patient safety first—and that speaks well of the house of medicine and its professional organizations.
Linos E, VanBeek M, Resneck JS. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer—Reply. JAMA Dermatol. 2015;151(9):1037. doi:10.1001/jamadermatol.2015.2007